4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-6-methyl-3-oxo-N-[(pyridin-2-yl)methyl]-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide
Chemical Structure Depiction of
4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-6-methyl-3-oxo-N-[(pyridin-2-yl)methyl]-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide
4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-6-methyl-3-oxo-N-[(pyridin-2-yl)methyl]-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide
Compound characteristics
| Compound ID: | L310-2376 |
| Compound Name: | 4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-6-methyl-3-oxo-N-[(pyridin-2-yl)methyl]-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide |
| Molecular Weight: | 443.48 |
| Molecular Formula: | C20 H21 N5 O5 S |
| Smiles: | CCc1nc(CN2C(COc3cc(c(C)cc23)S(NCc2ccccn2)(=O)=O)=O)no1 |
| Stereo: | ACHIRAL |
| logP: | 1.7834 |
| logD: | 1.7762 |
| logSw: | -2.6468 |
| Hydrogen bond acceptors count: | 12 |
| Hydrogen bond donors count: | 1 |
| Polar surface area: | 107.975 |
| InChI Key: | ROPYIPUZYVRODP-UHFFFAOYSA-N |